Tamsulosin "Krka" 0,4 mg kapsler med modificeret udløsning, hårde Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

tamsulosin "krka" 0,4 mg kapsler med modificeret udløsning, hårde

krka d.d. novo mesto - tamsulosinhydrochlorid - kapsler med modificeret udløsning, hårde - 0,4 mg

Lenalidomide Krka d.d. Европейски съюз - датски - EMA (European Medicines Agency)

lenalidomide krka d.d.

krka, d.d., novo mesto  - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - immunosuppressiva - multiple myelomalenalidomide krka d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) er indiceret til behandling af voksne patienter med tidligere ubehandlet myelomatose, der ikke er berettiget til transplantation. lenalidomide krka d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. follicular lymphomalenalidomide krka d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Vildagliptin/Metformin "Krka" 50+850 mg filmovertrukne tabletter Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

vildagliptin/metformin "krka" 50+850 mg filmovertrukne tabletter

krka d.d. novo mesto - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg